Nektar Therapeutics | 现金及等价物



金融业
股票价格
USD
资产
USD 301.35M
现金及等价物
USD 41.03M
销售成本
USD 4.44M
流动资产
USD 281.36M
流动负债
USD 66.34M
债务
USD 0
股息收益率
0
EBIT
USD -34.35M
EBITDA
USD -31.81M
员工
137
EPS每股收益
USD -0.18
股本和储备
USD 85.09M
销售毛利
USD 13.75M
债务利息支出
USD 6.02M
利息收入
USD -0.18
贷款资金
USD 107.51M
市值
USD 10.28B
净收入
USD -37.06M
营业费用
USD 85.09M
营业利润
USD -34.35M
普通股股本
USD 19K
税前利润
USD -37.05M
销售收入
USD 24.12M
销售和管理费用
USD -0.18
股票
USD 14.46M
贸易债权人
USD 15.56M
应收帐款人
USD 0


现金及等价物 更改 日
Agios Pharmaceuticals USD 92.71M 11.84M 2025-09
ALKERMES USD 616.45M 95.25M 2025-09
Alterity Therapeutics Limited AUD 15.77M 9.56M 2023-06
Amgen USD 9.13B 316M 2025-12
Baxter International USD 1.73B 40M 2025-09
BioCryst Pharmaceuticals USD 84.08M 3.95M 2025-09
Biogen USD 3.01B 854.3M 2025-12
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Cara Therapeutics USD 20.65M 13.57M 2025-06
Cipla INR 7.96B 39.9M 2025-09
Dr.Reddys Laboratories INR 18.66B 8.75B 2025-12
Eisai JPY 301.65B 16.27B 2025-09
Eli Lilly USD 9.79B 6.42B 2025-09
Esperion Therapeutics USD 92.45M 6.39M 2025-09
Exelixis USD 482.49M 106.19M 2025-12
Gilead Sciences USD 7.33B 2.19B 2025-09
GlaxoSmithKline GBP 3.3B 303M 2025-09
Grifols EUR 979.78M 334.84M 2024-12
Halozyme Therapeutics USD 419.66M 357.8M 2025-09
Incyte USD 3.58B 650.78M 2025-12
Ionis Pharmaceuticals USD 2.24B 1.94B 2025-09
Ironwood Pharmaceuticals USD 140.41M 47.56M 2025-09
Karyopharm Therapeutics USD 37.67M 1.05M 2025-09
MacroGenics USD 80.13M 50.56M 2025-09
Merck USD 18.17B 10.16B 2025-09
Nektar Therapeutics USD 41.03M 1.96M 2025-09
Neurocrine Biosciences USD 340.2M 76.2M 2025-09
Novartis USD 9.56B 2.9B 2025-09
Pfizer USD 1.34B 295M 2025-09
Roche Holding CHF 7.55B 579M 2025-06
Sarepta Therapeutics USD 613.08M 102.48M 2025-09
Takeda JPY 654.94B 26.55B 2025-12
Teva Pharmaceutical Industries USD 3.56B 1.35B 2025-12
Xencor USD 28.29M 16.15M 2025-09


Nektar Therapeutics 现金及等价物 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.